Lipoprotein(a) Clinical Trial
We are seeking adult individuals with high Atherosclerotic Cardiovascular Disease (ASCVD) risk for a clinical trial.
The study is evaluating the effect of an investigational Lp(a) lowering medication on primary event reduction.
Participation Eligibility
- 50 years of age or older
- Multiple risk factors for Atherosclerotic Cardiovascular Disease (e.g. Hypertension, Diabetes, etc.)
AND/OR
- History of Atherosclerosis (e.g. narrowing of 1 or more arteries, elevated Coronary Artery Calcium (CAC) score)
- Additional qualification criteria exist
Benefits
- Reimbursement for time and travel may be provided
- You are provided study-related care and study medicine (no health insurance required)
- You may help make a difference for yourself and for people like you
Research Study Location
Find Out If You Qualify
To learn more and find out if you qualify to participate, fill out the form below and a member of our team will be in touch to explain the available research studies.
Why Consider a Clinical Trial?
Clinical trials are conducted to help test investigational treatments for medical conditions and to determine if these investigational treatments are safe and effective. These research studies explore ways to potentially treat, diagnose or manage symptoms for diseases with the hope that they will improve quality of life for patients. Study-related care is provided at no cost. In addition to this, participants may help contribute to finding cures that may help future generations stay healthy.